pfizer
Three doses of Pfizer Covid vaccine better than two: Study
During the study period, the predominant variant was Delta and not Omicron
2 doses of Covid vaccines induce lower antibody levels against Omicron: Oxford study
The researchers noted that these data are important but are only one part of the picture
Pfizer Covid vaccine provides partial protection against Omicron: Study
The research finding indicated that ACE2 is required for Omicron entry
Pfizer results open door to new chapter for COVID-19 treatments
If the drugs are authorized by regulators, they are likely to overtake currently-available antibody treatments
Pfizer vaccine highly effective against Covid hospitalisations for six months: Study
The study underscores the importance of improving COVID-19 vaccination rates worldwide
FDA backs Pfizer COVID-19 boosters for seniors, high-risk
Under the FDA authorization, vaccinated Americans are eligible for a third dose six months after receiving their second Pfizer shot
Pfizer says COVID-19 vaccine works in kids ages 5 to 11
The vaccine made by Pfizer and its German partner BioNTech already is available for anyone 12 and older
How tech can help India reach vaccine goals and slow down its COVID-19 disaster
India’s vaccine chain has to protect against contamination before vaccines arrive, using tamper-proof seals and a transparent supply chain
New Zealand reports first death linked to Pfizer vaccine
The case has been referred to the coroner and the cause of death has not yet been determined
Indian govt's expert group in talks with Pfizer over COVID vaccine: Health Minister
The Health Ministry further informed the Parliament that Rs 9,725.15 crore have been spent so far on the COVID-19 vaccination programme